Your browser doesn't support javascript.
loading
[CRISPR/Cas9-mediated microRNA-21 knockout increased imatinib sensitivity in chronic myeloid leukemia cells].
Zhang, Y; Wang, L Y; Li, J Z; Jiang, P F; Hu, J D; Chen, B Y.
Affiliation
  • Zhang Y; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
  • Wang LY; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
  • Li JZ; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
  • Jiang PF; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
  • Hu JD; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
  • Chen BY; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(3): 243-249, 2021 Mar 14.
Article in Zh | MEDLINE | ID: mdl-33910311

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / MicroRNAs / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / MicroRNAs / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2021 Document type: Article Affiliation country: Country of publication: